First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

Clinical trial NCT05527184 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05527184
Sponsor: AbbVie
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrial Cancer High Grade Serous Adenocarcinoma of Ovary Primary Peritoneal Carcinoma Fallopian Tube Cancer Cervical Cancer

Start date: 2023-01-11
Primary completion: 2027-02-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.